Aytu Biopharma (AYTU) Capital Expenditures (2015 - 2026)
Aytu Biopharma (AYTU) reported Capital Expenditures of $12,000 for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 29.4% from $17,000 a year earlier.
Powered by 
Analysis
Aytu Biopharma (AYTU) Capital Expenditures (2015 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Aytu Biopharma posted Capital Expenditures of $29,000, down 87.3% from FY2025.
- Capital Expenditures has a five-year compound annual growth rate of -58.4% (FY2021 to FY2026).
- By fiscal year, Capital Expenditures came in at $228,000 in FY2025 (-30.7%) and $329,000 in FY2024.
- The fiscal Q4 2026 figure ranks as the lowest quarterly Capital Expenditures since fiscal Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -321.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -763.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Aytu Biopharma | 22.49 Mn | -93.18 Mn | 10.41 Mn | 12,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12,000.00 |
| Dec 31, 2025 | 17,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Mar 31, 2025 | 69,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Sep 30, 2024 | 136,000.00 |
| Jun 30, 2024 | 329,000.00 |
| Jun 30, 2021 | -13.06 Mn |
| Jun 30, 2020 | -5.85 Mn |
| Mar 31, 2020 | 1.35 Mn |
| Dec 31, 2019 | 4.50 Mn |
| Mar 31, 2019 | -300,000.00 |
| Dec 31, 2018 | 500,000.00 |
| Sep 30, 2018 | 300,000.00 |
| Jun 30, 2018 | 325,293.00 |
| Mar 31, 2018 | 62,512.00 |
| Dec 31, 2016 | 250,000.00 |
| Sep 30, 2016 | 500,000.00 |
| Jun 30, 2016 | 500,000.00 |
| Dec 31, 2015 | 536,446.00 |
API Access
Aytu Biopharma Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();